# Dulcolax vs Placebo in Functional Constipation

> **NCT00526097** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 368 (actual)

## Conditions studied

- Constipation

## Interventions

- **DRUG:** Bisacodyl 10 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00526097
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2009-06
- **Final completion:** —
- **Target enrollment:** 368 (ACTUAL)
- **Last updated:** 2014-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00526097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00526097, "Dulcolax vs Placebo in Functional Constipation". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00526097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*